Merchants Bancorp has just cleared its Q2 earnings hurdle, and the immediate read from the Street is cautious respect rather than conviction — Piper Sandler maintained its Overweight rating this morning but cut its price target from $64 to $58, a signal that the print was solid enough to hold but not enough to justify the prior enthusiasm.
The analyst picture has quietly shifted over recent weeks. Raymond James downgraded MBIN to Market Perform on July 1, stripping its Outperform rating without replacing it with a target. Morgan Stanley nudged its Equal-Weight target to $49 from $46 in late June, keeping its neutral stance intact. Today's Piper Sandler cut brings the mean target to $56.50 — still 16% above the current $48.77 close, which implies residual upside on paper. The analyst recommendation differential ranks in the 90th percentile of the ORTEX universe, a reflection of how few outright negative ratings sit on the name rather than genuine bullish clustering. The forward earnings picture scores reasonably well — EPS surprise ranks at the 70th percentile, and the 12-month forward EPS year-on-year increase scores at the 69th percentile — but EPS momentum over the past 30 and 90 days is weak, sitting in the low 20s percentile-rank range. Bears point to net interest margin compression and the 1% quarter-on-quarter NII decline flagged before the print; bulls lean on solid ROA of 0.94%, ROTCE of 10.6%, and strong deposit growth in the mortgage warehouse segment.
Short positioning, as detailed in yesterday's earnings preview note, has not materially changed post-results. Short interest remains at 3.4% of the free float — 1.56 million shares — essentially flat on the day after a brief 0.8% dip. The notable story from the past month still stands: shorts dropped nearly 30% in mid-July from around 2.2 million shares before partially rebuilding, and that rebuild has now stalled. Borrow costs are trivial at 0.44% — unchanged meaningfully on the week — and availability is generous at 257%, meaning more than 2.5 shares are available to borrow for every one already shorted. There is no squeeze dynamic here. The ORTEX short score has ticked up modestly to 62.7, its highest level in the 10-day window, but remains in a range that reflects moderate rather than elevated short pressure. Days-to-cover ranks in the 1st percentile of the universe — shorts could exit almost instantly if they needed to.
The ownership structure adds important context. Founder-linked entities hold a dominant stake, with Elser Financial Planning controlling 58% of shares and CEO Michael Petrie holding a further 27%. BlackRock added 2.17 million shares as of June 30, a meaningful institutional step-up. That said, Petrie himself was a consistent seller in the 90-day window ending May 6, offloading roughly 39,000 shares across several transactions worth approximately $1.83 million — all at prices between $41 and $47, below the current level. The net insider position over that window shows net selling of $2.74 million. The stock has since moved higher, trading at $48.77, which gives the insider sales some context: they occurred before the current price level was established.
The options market has calmed from its most defensive posture. The put/call ratio dropped to 1.13 on the day of the print, well below its 20-day average of 1.35, after running above 2.0 for several sessions in mid-July. That retreat in put demand, now confirmed post-announcement, suggests the hedging was event-driven rather than a structural view on the stock. The PCR z-score is -0.56, meaning options positioning is actually slightly less bearish than average — a mild reversal from the defensive stance of two weeks ago.
The next scheduled earnings event is October 29. Between now and then, the key variables to watch are whether Raymond James reinitiates with a target following its downgrade, whether the short interest rebuild continues or fades, and how the NII and margin trends evolve as the rate environment develops into the back half of the year.
See the live data behind this article on ORTEX.
Open MBIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
